Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMILE: Iguratimod in Rheumatoid Arthritis
NCT01548001Phase 4Unknown
- Sponsor
- Simcere Pharmaceutical Group
- Start
- May 2012
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iguratimod in rheumatoid arthritis (RA), sponsored by Simcere Pharmaceutical Group. Status: unknown.
02
Drugs
iguratimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01548001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01548001.